Precigen Cash Flow Statement
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.81+0.21 (+2.76%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Precigen free cash flow
In fiscal 2025, Precigen generated -$87.8 million of operating cash flow and spent $2.0 million on capital expenditures. That left free cash flow of -$89.8 million, a free-cash-flow margin of -927.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Precigen cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -250.64M | -126.23M | -95.90M | 28.32M | -92.17M | -170.52M | -323.92M | -514.71M | -126.82M | -190.27M |
| Net Income growth (YoY) | — | — | -438.68% | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.20M | 4.53M | 6.67M | 10.77M | 13.76M | 17.52M | 24.90M | 33.11M | 31.14M | 24.57M |
| Stock-Based Compensation | 10.87M | 9.47M | 9.89M | 10.21M | 13.90M | 18.37M | 18.95M | 36.30M | 41.58M | 42.20M |
| Change in Working Capital | -5.99M | 1.84M | -1.73M | -22.95M | -5.75M | -17.56M | 6.25M | -36.42M | -78.35M | -13.28M |
| Operating Cash Flow | -87.83M | -68.17M | -66.93M | -65.05M | -55.77M | -77.02M | -135.93M | -124.24M | -103.72M | -48.99M |
| Capital Expenditures | -2.00M | -8.58M | -1.54M | -4.92M | -7.25M | -7.53M | -37.88M | -41.59M | -46.67M | -31.63M |
| Investing Cash Flow | -1.53M | -20.71M | -3.09M | 226.42M | -74.54M | 27.78M | 86.85M | -151.21M | 104.33M | -28.39M |
| Debt Issued | 92.82M | 0 | 0 | — | 0 | 0 | 376.00K | 219.86M | 325.00K | 547.00K |
| Debt Repaid | 0 | 0 | -43.22M | -155.29M | -466.00K | -490.00K | -618.00K | -623.00K | -519.00K | -1.20M |
| Financing Cash Flow | 90.05M | 110.58M | 29.59M | -155.29M | 121.19M | 32.70M | 8.14M | 309.80M | 4.28M | 12.06M |
| Net Change in Cash | 717.00K | 21.67M | -40.75M | 5.25M | -8.91M | -16.18M | -41.75M | 34.64M | 5.95M | -66.19M |
| Free Cash Flow | -89.83M | -76.76M | -68.47M | -69.97M | -63.02M | -84.55M | -173.81M | -165.83M | -150.39M | -80.62M |
This table shows 10 annual periods of Precigen's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PGEN's reporting calendar. What is a cash flow statement?